Quarterly Transactions Made in Y M Abs Therapeutics, Inc. (YMAB)
This table provides information about the institutional ownership of Y M Abs Therapeutics, Inc. (YMAB). The information is specifically focused on institutions that hold shares of Y-mAbs Therapeutics, Inc..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 1,820,482 | 1,163,285 | 2,983,767 | 1,347,853 | 347,242 | 1,695,095 | 1,288,672 | |
Q4 2021 | 1,595,734 | 547,714 | 2,143,448 | 1,376,303 | 1,095,041 | 2,471,344 | -327,896 | |
Q1 2022 | 5,271,262 | 256,752 | 5,528,014 | 3,532,709 | 2,247,516 | 5,780,225 | -252,211 | |
Q2 2022 | 679,603 | 893,845 | 1,573,448 | 2,415,011 | 48,002 | 2,463,013 | -889,565 | |
Q3 2022 | 693,131 | 599,848 | 1,292,979 | 2,348,463 | 0 | 2,348,463 | -1,055,484 | |
Q4 2022 | 3,365,562 | 2,388,303 | 5,753,865 | 6,108,522 | 0 | 6,108,522 | -354,657 | |
Q1 2023 | 1,808,240 | 1,365,593 | 3,173,833 | 2,234,033 | 0 | 2,234,033 | 939,800 | |
Q2 2023 | 2,706,219 | 1,114,731 | 3,820,950 | 1,914,950 | 0 | 1,914,950 | 1,906,000 | |
Q3 2023 | 1,181,311 | 55,618 | 1,236,929 | 1,031,677 | 0 | 1,031,677 | 205,252 | |
Q4 2023 | 1,725,980 | 292,832 | 2,018,812 | 1,497,192 | 0 | 1,497,192 | 521,620 | |
Q1 2024 | 1,029,272 | 4,914,226 | 5,943,498 | 2,313,410 | 0 | 2,313,410 | 3,630,088 | |
Q2 2024 | 2,470,684 | 1,767,198 | 4,237,882 | 2,523,381 | 1,200 | 2,524,581 | 1,713,301 | |
Q3 2024 | 1,393,369 | 932,749 | 2,326,118 | 1,450,293 | 0 | 1,450,293 | 875,825 |